← Back to Search

Cognitive Task Analysis for Epilepsy and Brain Cancer

N/A
Recruiting
Led By Nitin Tandon, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, during stimulation( about 2 seconds after baseline )
Awards & highlights

Summary

This trial compares how normal brain function is organized using fMRI in normal people and those with epilepsy or brain tumors, to understand the role of specific brain regions in cognitive processes.

Who is the study for?
This trial is for English-speaking patients with medically refractory epilepsy or brain tumors near crucial brain regions. They may have electrodes implanted to locate seizure sites and map critical areas, or they might undergo intra-op mapping, a Wada test, or an awake craniotomy.
What is being tested?
The study aims to compare normal brain function using fMRI in healthy subjects versus those with epilepsy or brain tumors. It involves language-based tasks and will use data from intracranial recordings to analyze information flow between brain areas.
What are the potential side effects?
There are no direct side effects mentioned for participating in this trial since it involves non-invasive imaging and cognitive tests. However, there could be general risks associated with fMRI scanning such as discomfort from lying still.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, during stimulation( about 2 seconds after baseline )
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, during stimulation( about 2 seconds after baseline ) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in reaction times in milliseconds

Trial Design

1Treatment groups
Experimental Treatment
Group I: Neural recordings and stimulation during language tasksExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
934 Previous Clinical Trials
333,733 Total Patients Enrolled
6 Trials studying Epilepsy
318 Patients Enrolled for Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,362 Previous Clinical Trials
650,675 Total Patients Enrolled
77 Trials studying Epilepsy
25,078 Patients Enrolled for Epilepsy
Nitin Tandon, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
8 Total Patients Enrolled
1 Trials studying Epilepsy
8 Patients Enrolled for Epilepsy

Media Library

Neural recordings and stimulation during language tasks Clinical Trial Eligibility Overview. Trial Name: NCT05989893 — N/A
Epilepsy Research Study Groups: Neural recordings and stimulation during language tasks
Epilepsy Clinical Trial 2023: Neural recordings and stimulation during language tasks Highlights & Side Effects. Trial Name: NCT05989893 — N/A
Neural recordings and stimulation during language tasks 2023 Treatment Timeline for Medical Study. Trial Name: NCT05989893 — N/A
~43 spots leftby Jul 2027